For years, fertility medications were one of the biggest and least controllable costs in IVF—sometimes costing more than the procedure itself. Then, almost overnight, prices dropped by nearly 50%.

In this episode, Dr. Mark Amols explains what actually caused this dramatic shift, how government policy and pharmaceutical competition reshaped pricing, and why this change is already affecting IVF protocols. He breaks down what lower gonadotropin costs mean for patients, how this impacts the use of Menopur, and why low-dose hCG is now becoming a more cost-effective alternative for LH activity in many cycles.

If you’re preparing for IVF, freezing eggs, or struggling with medication costs, this episode will help you understand how these changes can affect your treatment, your budget, and your options.

Thanks for tuning in to another episode of 'Taco Bout Fertility Tuesday' with Dr. Mark Amols. If you found this episode insightful, please share it with friends and family who might benefit from our discussion. Remember, your feedback is invaluable to us – leave us a review on Apple Podcasts, Spotify, or your preferred listening platform.

Stay connected with us for updates and fertility tips – follow us on Facebook. For more resources and information, visit our website at www.NewDirectionFertility.com.

Have a question or a topic you'd like us to cover? We'd love to hear from you! Reach out to us at TBFT@NewDirectionFertility.com.

Join us next Tuesday for more discussions on fertility, where we blend medical expertise with a touch of humor to make complex topics accessible and engaging. Until then, keep the conversation going and remember: understanding your fertility is a journey we're on together.

Why IVF Medications Just Got Cheaper (and What That Changes)